Overview of the European Medicines Agency (EMA), Part 1 of 3

Overview of the European Medicines Agency (EMA), Part 1 of 3

42:31 |

Related Videos

WALS NIH Director's Lecture: The Future of CRISPR: What’s Ahead for Genome Editing

1:00:18

WALS NIH Director's Lecture: The Future of CRISPR: What’s Ahead for Genome Editing

The Promises and Perils of AI in Biomedical Research and Health Care Delivery

1:07:31

The Promises and Perils of AI in Biomedical Research and Health Care Delivery

WALS "Quantitative Proteomics for Understanding Epigenetics Mechanisms"

1:03:05

WALS "Quantitative Proteomics for Understanding Epigenetics Mechanisms"

You contain multitudes: Somatic mutation and genomic diversity in human brain

1:03:35

You contain multitudes: Somatic mutation and genomic diversity in human brain

Regenerating and Rejuvenating Aged Tissues by Targeting a Gerozyme

1:02:49

Regenerating and Rejuvenating Aged Tissues by Targeting a Gerozyme

2024 National Academy of Sciences Mini–Symposium

2:15:49

2024 National Academy of Sciences Mini–Symposium

Cryptic Changes that Result from Perturbations and Climate Change Shape Future Dynamics...

1:00:46

Cryptic Changes that Result from Perturbations and Climate Change Shape Future Dynamics...

2024 Symposium of the NIH Distinguished Scholars Program, Part 1

1:54:41

2024 Symposium of the NIH Distinguished Scholars Program, Part 1

2024 Symposium of the NIH Distinguished Scholars Program, Part 2

2:32:50

2024 Symposium of the NIH Distinguished Scholars Program, Part 2

Hematology from the Ground-Up: Lessons from Bloodless Worms

1:04:17

Hematology from the Ground-Up: Lessons from Bloodless Worms

Gaining New Insights into 'Fundamental Immunology' Using Imaging and Computation

1:16:34

Gaining New Insights into 'Fundamental Immunology' Using Imaging and Computation

Overcoming the Undruggable Nature of the Most Common Human Oncogene K-Ras

1:01:44

Overcoming the Undruggable Nature of the Most Common Human Oncogene K-Ras

IPPCR 2019 Overview of NIH Inclusion Policies

11:45

IPPCR 2019 Overview of NIH Inclusion Policies

Sugar and the beating heart: the conundrum of heart failure in diabetes

1:02:51

Sugar and the beating heart: the conundrum of heart failure in diabetes

Decoding genetic skin disorders: lessons and new technologies

53:04

Decoding genetic skin disorders: lessons and new technologies

NIH Peer Review Process Part 1 of 4

17:36

NIH Peer Review Process Part 1 of 4

Getting to the “Heart” of Cardiometabolic Health Disparities

59:00

Getting to the “Heart” of Cardiometabolic Health Disparities

Introduction to Clinical Study Design: Where to Start Part 1

16:00

Introduction to Clinical Study Design: Where to Start Part 1

WALS: Biospecific Chemistry for Covalent Linking of Biomacromolecules

1:03:00

WALS: Biospecific Chemistry for Covalent Linking of Biomacromolecules

IPPCR - Disasters and Other Humanitarian Crises Part 3 of 4

26:11

IPPCR - Disasters and Other Humanitarian Crises Part 3 of 4